Tune Insight, a Zurich, Switzerland-based company providing confidential collaborative analytics and federated machine learning B2B solutions, raised $3.4 million in funding.
The round was led by 14Peaks Capital, with participation from Inflection.xyz, Debiopharm, Zurich Cantonal Bank, and existing investor Wingman Ventures.
14Peaks is an early-stage investor in B2B SaaS companies located in Europe and the US. Within SaaS, the focus is across three core verticals: fintech, proptech, and the future of work. Founded in 2022, and is based in Zug, Switzerland.
Tune Insight Use of Funds
The company intends to use the funds to strengthen its position for confidential collaborative analytics and machine learning in healthcare, financial services, and cybersecurity, strengthen sales and marketing teams, and accelerate international expansion in Europe and the US.
About Tune Insight
Tune Insight develops an encrypted computing platform for data collaborations, valorization, and machine learning with sensitive and confidential data. Its vision is to replace the data economy with a secure insight economy where raw, sensitive data doesn’t move and is never revealed, enabling companies to collaborate and valorize their data and models, without ever losing control of their value.
Today, Tune Insight is deployed at University Hospital Zurich, CHUV in Lausanne, Inselspital in Bern, Switzerland, and powers applications such as survival analysis for precision oncology and personalized reference ranges.
Company: Tune Insight SA
Funding Month: September 2023
Lead Investors: 14Peaks Capital
Additional Investors: Inflection.xyz, Debiopharm, Zurich Cantonal Bank and Wingman Ventures
Company Website: https://tuneinsight.com/
Software Category: Computing Platform